Trial Profile
A phase III trial of bedoradrine [MN 221] for acute exacerbations of asthma.
Status:
Planning
Phase of Trial:
Phase III
Latest Information Update: 30 Jun 2008
Price :
$35
*
At a glance
- Drugs Bedoradrine (Primary)
- Indications Acute asthma
- Focus Registrational; Therapeutic Use
- 30 Jun 2008 New trial record.